Cargando…

The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress

The formation of an atheroma begins when lipoproteins become trapped in the intima. Entrapped lipoproteins become oxidized and activate the innate immune system. This immunity represents the primary association between lipids and inflammation. When the trapping continues, the link between lipids and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bale, Bradley Field, Doneen, Amy Lynn, Leimgruber, Pierre P., Vigerust, David John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682196/
https://www.ncbi.nlm.nih.gov/pubmed/36439997
http://dx.doi.org/10.3389/fcvm.2022.1042729
_version_ 1784834796974768128
author Bale, Bradley Field
Doneen, Amy Lynn
Leimgruber, Pierre P.
Vigerust, David John
author_facet Bale, Bradley Field
Doneen, Amy Lynn
Leimgruber, Pierre P.
Vigerust, David John
author_sort Bale, Bradley Field
collection PubMed
description The formation of an atheroma begins when lipoproteins become trapped in the intima. Entrapped lipoproteins become oxidized and activate the innate immune system. This immunity represents the primary association between lipids and inflammation. When the trapping continues, the link between lipids and inflammation becomes chronic and detrimental, resulting in atherosclerosis. When entrapment ceases, the association between lipids and inflammation is temporary and healthy, and the atherogenic process halts. Therefore, the link between lipids and inflammation depends upon lipoprotein retention in the intima. The entrapment is due to electrostatic forces uniting apolipoprotein B to polysaccharide chains on intimal proteoglycans. The genetic transformation of contractile smooth muscle cells in the media into migratory secretory smooth muscle cells produces the intimal proteoglycans. The protein, platelet-derived growth factor produced by activated platelets, is the primary stimulus for this genetic change. Oxidative stress is the main stimulus to activate platelets. Therefore, minimizing oxidative stress would significantly reduce the retention of lipoproteins. Less entrapment decreases the association between lipids and inflammation. More importantly, it would halt atherogenesis. This review will analyze oxidative stress as the critical link between lipids, inflammation, and the pathogenesis of atherosclerosis. Through this perspective, we will discuss stopping oxidative stress to disrupt a harmful association between lipids and inflammation. Numerous therapeutic options will be discussed to mitigate oxidative stress. This paper will add a new meaning to the Morse code distress signal SOS-stopping oxidative stress.
format Online
Article
Text
id pubmed-9682196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96821962022-11-24 The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress Bale, Bradley Field Doneen, Amy Lynn Leimgruber, Pierre P. Vigerust, David John Front Cardiovasc Med Cardiovascular Medicine The formation of an atheroma begins when lipoproteins become trapped in the intima. Entrapped lipoproteins become oxidized and activate the innate immune system. This immunity represents the primary association between lipids and inflammation. When the trapping continues, the link between lipids and inflammation becomes chronic and detrimental, resulting in atherosclerosis. When entrapment ceases, the association between lipids and inflammation is temporary and healthy, and the atherogenic process halts. Therefore, the link between lipids and inflammation depends upon lipoprotein retention in the intima. The entrapment is due to electrostatic forces uniting apolipoprotein B to polysaccharide chains on intimal proteoglycans. The genetic transformation of contractile smooth muscle cells in the media into migratory secretory smooth muscle cells produces the intimal proteoglycans. The protein, platelet-derived growth factor produced by activated platelets, is the primary stimulus for this genetic change. Oxidative stress is the main stimulus to activate platelets. Therefore, minimizing oxidative stress would significantly reduce the retention of lipoproteins. Less entrapment decreases the association between lipids and inflammation. More importantly, it would halt atherogenesis. This review will analyze oxidative stress as the critical link between lipids, inflammation, and the pathogenesis of atherosclerosis. Through this perspective, we will discuss stopping oxidative stress to disrupt a harmful association between lipids and inflammation. Numerous therapeutic options will be discussed to mitigate oxidative stress. This paper will add a new meaning to the Morse code distress signal SOS-stopping oxidative stress. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9682196/ /pubmed/36439997 http://dx.doi.org/10.3389/fcvm.2022.1042729 Text en Copyright © 2022 Bale, Doneen, Leimgruber and Vigerust. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Bale, Bradley Field
Doneen, Amy Lynn
Leimgruber, Pierre P.
Vigerust, David John
The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title_full The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title_fullStr The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title_full_unstemmed The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title_short The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
title_sort critical issue linking lipids and inflammation: clinical utility of stopping oxidative stress
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682196/
https://www.ncbi.nlm.nih.gov/pubmed/36439997
http://dx.doi.org/10.3389/fcvm.2022.1042729
work_keys_str_mv AT balebradleyfield thecriticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT doneenamylynn thecriticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT leimgruberpierrep thecriticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT vigerustdavidjohn thecriticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT balebradleyfield criticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT doneenamylynn criticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT leimgruberpierrep criticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress
AT vigerustdavidjohn criticalissuelinkinglipidsandinflammationclinicalutilityofstoppingoxidativestress